Oracle Corporation (NYSE:ORCL) Shares Purchased by Continuum Advisory LLC

Continuum Advisory LLC grew its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 17.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 24,131 shares of the enterprise software provider's stock after buying an additional 3,640 shares during the period. Continuum Advisory LLC's holdings in Oracle were worth $3,374,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Norges Bank purchased a new stake in Oracle during the fourth quarter valued at about $2,216,314,000. Raymond James Financial Inc. purchased a new stake in shares of Oracle in the fourth quarter worth about $930,095,000. GAMMA Investing LLC boosted its position in shares of Oracle by 15,012.3% in the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock worth $664,810,000 after buying an additional 4,723,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Oracle by 20.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock worth $2,303,858,000 after buying an additional 2,350,448 shares during the period. Finally, Vanguard Group Inc. boosted its position in shares of Oracle by 1.5% in the fourth quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock worth $26,231,127,000 after buying an additional 2,296,069 shares during the period. Hedge funds and other institutional investors own 42.44% of the company's stock.

Insider Activity

In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the business's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $190.42, for a total value of $76,168,000.00. Following the transaction, the insider now directly owns 1,097,576 shares in the company, valued at $209,000,421.92. The trade was a 26.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Clayton M. Magouyrk sold 15,000 shares of Oracle stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $214.10, for a total value of $3,211,500.00. Following the completion of the sale, the insider now directly owns 60,722 shares of the company's stock, valued at approximately $13,000,580.20. This trade represents a 19.81% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 442,366 shares of company stock valued at $83,395,223. Insiders own 42.20% of the company's stock.

Oracle Trading Down 2.8%

Shares of NYSE:ORCL opened at $205.06 on Monday. The company's 50-day moving average price is $160.39 and its two-hundred day moving average price is $161.16. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75. Oracle Corporation has a one year low of $118.86 and a one year high of $216.60. The stock has a market capitalization of $575.96 billion, a PE ratio of 47.25, a price-to-earnings-growth ratio of 3.08 and a beta of 1.32.

Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The company had revenue of $15.90 billion for the quarter, compared to analysts' expectations of $15.58 billion. During the same period last year, the firm earned $1.63 earnings per share. The business's revenue for the quarter was up 11.3% on a year-over-year basis. On average, equities analysts forecast that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Thursday, July 10th. Oracle's payout ratio is currently 46.08%.

Analysts Set New Price Targets

ORCL has been the subject of several analyst reports. Westpark Capital upped their target price on Oracle from $195.00 to $246.00 and gave the stock a "buy" rating in a research report on Thursday, June 12th. Monness Crespi & Hardt upgraded Oracle from a "sell" rating to a "neutral" rating in a research note on Monday, March 3rd. The Goldman Sachs Group reiterated a "neutral" rating and issued a $195.00 price target (up previously from $145.00) on shares of Oracle in a research note on Friday, June 13th. Barclays reiterated an "overweight" rating and issued a $221.00 price target (up previously from $202.00) on shares of Oracle in a research note on Friday, June 13th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $240.00 price target (up previously from $200.00) on shares of Oracle in a research note on Thursday, June 12th. Eleven investment analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, Oracle currently has a consensus rating of "Moderate Buy" and a consensus target price of $196.74.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.